RecruitingPhase 3NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Sponsor: Merck Sharp & Dohme LLCCharlotte, NC · Winston-Salem, NC · +52 more sites
RecruitingPhase not listedNCT02071134Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistrySponsor: Boston Scientific CorporationWinston-Salem, NC · +28 more sites
RecruitingPhase 3NCT06989112DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerSponsor: AstraZenecaCharlotte, NC · Winston-Salem, NC · +60 more sites
RecruitingPhase not listedNCT03664609Deep Brain Stimulation (DBS) Retrospective Outcomes StudySponsor: Boston Scientific CorporationWinston-Salem, NC · +9 more sites
RecruitingPhase 4NCT06765668A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseSponsor: Impax Laboratories, LLCWinston-Salem, NC · +26 more sites